: $Actelis Networks(ASNS)$ 中概退潮,玩你们俩兄弟够了,神经病一样的庄,疯狂的手法查看全文
usbiostock2018-06-28 19:46
$Arsanis, Inc.(ASNS)$ 公司宣布ASN100预防金黄色葡萄球菌肺炎临床2期试验未能达到主要终点,公司将终止该药的研发。公司重点将放在ASN500,用于预防呼吸道合胞病毒感染。查看全文
美股医药Z博士2017-12-12 11:33
$Arsanis, Inc.(ASNS)$ 来推荐一只IPO不久的股票,喜欢短线的朋友可以关注。公司具有很多极具潜力的单抗抗生素药物,目前股价已跌破发行价。今日两大投行提高它的评级,并给出23的目标价,结果有意思的是股价居然-12%。是个不错的短线机会,第一个目标价16左右。查看全文
$Actelis Networks(ASNS)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-22-027745 Size: 9 KB 网页链接
$Actelis Networks(ASNS)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-22-027747 Size: 5 KB 网页链接
$Actelis Networks(ASNS)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-22-027738 Size: 8 KB 网页链接
$Actelis Networks(ASNS)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-22-027739 Size: 2 KB 网页链接
$Actelis Networks(ASNS)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-22-027740 Size: 5 KB 网页链接
$Actelis Networks(ASNS)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-22-027741 Size: 2 KB 网页链接
$Actelis Networks(ASNS)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-22-027742 Size: 2 KB 网页链接
$Actelis Networks(ASNS)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-22-027733 Size: 9 KB 网页链接
$Actelis Networks(ASNS)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-22-027735 Size: 5 KB 网页链接
$Actelis Networks(ASNS)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-22-027736 Size: 8 KB 网页链接